STAAR Surgical Company (STAA): insider & executive buying
STAAR Surgical Company · Health Care · ref. ETF XLV · price $22.39
In short — 1 insider bought STAAR Surgical Company over ~6 months (1 buy, total $12.3M, latest Mar 11, 26). Public Form 4 data, informative (not a performance signal).
Are STAAR Surgical Company's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$22.39-18.3% over range
Aug 28, 25low $16.1 · high $33.34Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
29% recommend buying · 7 analysts
Latest insider buys on STAAR Surgical Company
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| Mar 11, 26 | Broadwood Partners, L.P. | Dir, 10% | 670,213 | $12.3M |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have STAAR Surgical Company's executives bought shares recently?
1 STAAR Surgical Company insider(s) bought $12.3M over ~6 months (latest Mar 11, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for STAA?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about STAAR Surgical Company? The JPI assistant answers using our backtest data.
Keep exploring STAAR Surgical Company